Riskpilot← Back to searchSign inGet full accessTreMedikus AB
ABBankruptOrg 5590876313Medical specialists activities · NACE 8622Est. 20164 employees
Revenue 2020
SEK 4,8M
+29% vs 2019
EBITDA margin
1.4%
-88% vs 2019
Equity ratio
36.2%
Financial strength
Net profit 2020
SEK 28K
-93% vs 2019
| Revenue | SEK 4,8M | +29% |
| EBITDA | SEK 66K | -88% |
| Net profit | SEK 28K | -93% |
| Total assets | SEK 790K | -32% |
| Equity | SEK 286K | -63% |
| Employees | 4 | — |
Legal name
TreMedikus AB
Org number
5590876313
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
29 november 2016
Share capital
SEK 0
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-10-31
Financial year
January – December
Company purpose
Specialistläkarmottagning inom allmän internmedicin och gastroenterologi
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Revenue | 614 | 2 659 | 3 703 | 4 777 |
| Staff expenses | — | — | — | — |
| EBITDA | 294 | 368 | 564 | 66 |
| Depreciation & amort. | −8 | −28 | −32 | −34 |
| EBIT | 286 | 340 | 532 | 32 |
| Net financials | — | — | −1 | −1 |
| Profit before tax | 256 | 338 | 533 | 43 |
| Tax | −58 | −78 | −124 | −15 |
| Net profit | 198 | 260 | 409 | 28 |
| Item | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Total assets | 421 | 816 | 1 168 | 790 |
| Equity | 249 | 434 | 768 | 286 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 142 | 350 | 370 | 485 |
| Total debt | 142 | 350 | 370 | 485 |
EBITDA margin
1.4%
This company
15.8%
Market median
-91% vs market
20172020
Equity ratio
36.2%
This company
38.2%
Market median
+5% vs market
20172020
Return on equity
9.8%
This company
18.4%
Market median
-47% vs market
20172020
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20172020
Asset turnover
6.05×
This company
1.12×
Market median
+440% vs market
20172020
Debt / equity
1.76×
This company
0.62×
Market median
-184% vs market
20172020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-10-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-11-01 – 2019-10-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-11-01 – 2018-10-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-11-01 – 2017-10-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BA Chief Executive Officer | Chief Executive Officer | 2021 |
JM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TreMedikus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Axel Emanuel Josefsson | Chief Executive Officer | 0 companies |
| Johan Martin Waern | Deputy Chief Executive Officer | 0 companies |
| Marcus Karl-Erik Hesselmar | Chairman | 0 companies |